Table 5.

Ceramide score and risk for cardiovascular death

BECAC (5-year risk)					SPUM-ACS (1-year risk)
Score	No death	Death	%	Relative risk	Score	No death	Death	%	Relative risk
0–2	534	15	2.7%	1.0	0–2	566	9	1.6%	1.0
3–6	572	29	4.8%	1.8	3–6	595	16	2.6%	1.7
7–9	268	20	6.9%	2.5	7–9	261	9	3.3%	2.1
10–12	132	17	11.4%	4.2	10–12	164	17	9.4%	6.0
LDL-C (mg/dl)	No death	Death	%	Relative risk	LDL-C (mg/dl)	No death	Death	%	Relative risk
≤100	513	36	6.6%	1.0	≤106	532	27	4.8%	1.0
100–143	572	29	4.8%	0.7	106–145	576	17	2.9%	0.6
143–175	278	10	3.5%	0.5	145–174	260	3	1.1%	0.2
≥175	142	6	4.1%	0.6	≥174	174	2	1.1%	0.2

See Supplementary material online, Table S11 for information on Ceramide Score calculation. To compare Ceramide Score performance with that of LDL-C study, subjects were sorted according to their LDL-C levels and split into four categories in the same proportion as for the ceramide risk score.